<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02189798</url>
  </required_header>
  <id_info>
    <org_study_id>CR0114</org_study_id>
    <nct_id>NCT02189798</nct_id>
  </id_info>
  <brief_title>Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness</brief_title>
  <official_title>Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advanced Bionics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Advanced Bionics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this feasibility study is to evaluate whether low-frequency acoustic hearing
      sensitivity can be preserved in newly implanted adults with partial deafness (considerable
      low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural
      hearing loss) using the HiResolution™ 90K™ Advantage cochlear implant with the HiFocus™
      Mid-Scala electrode to support the development of electro-acoustic stimulation technology
      (EAS).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The two main arms are conducted in parallel. The third arm is optional for subjects who complete either of the two main arms using the EAS sound processor.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Unaided pure-tone hearing threshold measurements</measure>
    <time_frame>Three months</time_frame>
    <description>Unaided pure tone hearing threshold measurement in the implanted ear 3 months after surgery compared to pre-implant audiometric thresholds (using pure-tone average of 125 - 1000 Hz for comparison)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Speech perception testing</measure>
    <time_frame>Up to 19 months</time_frame>
    <description>Speech perception testing (in quiet and noise) in the treated ear compared to pre-implant speech perception testing (in quiet and noise)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire data</measure>
    <time_frame>Up to 19 months</time_frame>
    <description>Speech, Spatial Qualities (SSQ) questionnaire, Abbreviated Profile of Hearing Aid Benefits (APHAB) and Sponsored Development questionnaires post-implant compared to pre-implant condition</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hearing Loss</condition>
  <condition>Partial Deafness</condition>
  <condition>Hearing Disorders</condition>
  <condition>Ear Diseases</condition>
  <condition>Otorhinolaryngologic Diseases</condition>
  <arm_group>
    <arm_group_label>Newly Implanted Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode will be implanted in adults with partial deafness. Patients retaining considerable low frequency acoustic hearing after the surgery, will be fitted with the EAS sound processor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Existing Implanted Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adults unilaterally implanted with HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode with partial deafness will be fitted with the EAS sound processor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EAS Extended Use Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adults who are unilaterally implanted with HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode with partial deafness and completed the 12 Month visit using the EAS sound processor in either the Newly Implanted Group or Existing Implanted Group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode</intervention_name>
    <description>HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode will be implanted in adults with partial deafness (considerable low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural hearing loss).</description>
    <arm_group_label>Newly Implanted Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EAS sound processor</intervention_name>
    <description>Patients with partial deafness (considerable low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural hearing loss) implanted with HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode will be fitted with the EAS sound processor.</description>
    <arm_group_label>Newly Implanted Group</arm_group_label>
    <arm_group_label>Existing Implanted Group</arm_group_label>
    <arm_group_label>EAS Extended Use Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: Newly Implanted Group:

          -  Ability to provide informed consent

          -  No previous cochlear implant experience in either ear

          -  18 years of age or older

          -  Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone
             average ≤65 dB for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural
             hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 3000,
             4,000, and 8,000 Hz) in the ear to be implanted

          -  Aided CNC word recognition score up to 50% in ear to be implanted

          -  Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone
             average ≤65 dB for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural
             hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 3000,
             4,000, and 8,000 Hz) in the contralateral (non-implanted) ear

          -  Aided CNC word recognition score up to 80% in the contralateral ear

          -  English language proficiency

          -  Willingness to use an ear-level sound processor postoperatively for the duration of
             the study trial

          -  Willingness to participate in all scheduled procedures outlined in the protocol

        Exclusion Criteria: Newly Implanted Group:

          -  Preoperative audiometric conductive overlay of 15 dB or greater at two frequencies or
             more in range of 500-1000 Hz in the ear to be implanted

          -  Congenital hearing loss (for purpose of this study, onset prior to age 2 years*).
             *Based on critical period for speech and language development

          -  Duration greater than 30 years of severe-to-profound high-frequency hearing loss

          -  Cochlear malformation or obstruction that would preclude full insertion of electrode
             array in the ear to be implanted

          -  Medical or psychological conditions that contraindicate surgery or impact the ability
             to manage an implanted device or the study related procedures as determined by the
             investigator

          -  Deafness due to central auditory lesion or cochlear nerve deficiency, diagnosis of
             auditory neuropathy/dys-synchrony in either the ear to be implanted or the
             contralateral ear

          -  Active middle-ear disease/infection in the ear to be implanted

          -  Unrealistic expectations regarding potential benefits, risks and limitations inherent
             to implant surgical procedures as determined by the investigator

          -  Unwillingness or inability of subject to comply with all investigational requirements
             as determined by the investigator

        EAS Fitting Inclusion Criteria: Newly Implanted and Existing Implanted Groups

          -  Ability to provide informed consent

          -  18 years of age or older, unilaterally implanted with HiRes90K™ Advantage cochlear
             implant with HiFocus™ Mid-Scala electrode and fit with an ear-level sound processor
             (i.e. Naída family device)

          -  Postoperative unaided low frequency audiometric hearing thresholds in the treated ear
             up to 80 dB HL for at least one frequency from 125 - 1000 Hz

          -  English Language Proficiency

          -  Willingness to participate in all scheduled procedures outlined in the study protocol

        EAS Fitting Exclusion Criteria: Newly Implanted and Existing Implanted Groups

          -  Unilaterally implanted with HiRes 90K™ Advantage cochlear implant with HiFocus™ Helix®
             and HiFocus™ 1j electrode

          -  Exclusive use of a body worn external sound processor

          -  Deafness due to central auditory lesion or cochlear nerve deficiency, diagnosis of
             auditory neuropathy/dys-synchrony in either the implanted or the contralateral ear

          -  Postoperative unaided low frequency audiometric hearing thresholds in the treated ear
             exceeding 80 dB HL at each frequency from 125 - 1000 Hz Unwillingness or inability of
             subject to comply with all investigational requirements as determined by the
             investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert D Cullen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Midwest Ear Institute, Saint Louis, Missouri</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Loren J Bartels, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampa Bay Hearing and Balance Center, Tampa, Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Haynes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt Bill Wilkerson Center, Nashville, Tennessee</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard A Chole, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University, Saint Louis, Missouri</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J Thomas Roland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University Langone Medical Center, New York, New York</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Colin LW Driscoll, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic Rochester, Rochester, Minnesota</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Luxford, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>House Clinic, Los Angeles, California</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Betty Tsai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma Ear Institute, Oklahoma City, Oklahoma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthew Bush, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky Medical Center, Lexington, Kentucky</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arnaldo Rivera, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Missouri, Columbia, Missouri</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Kemper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Austin Ear, Nose &amp; Throat Clinic, Austin, Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Hoa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Georgetown University School of Medicine, Washington, District of Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elina Kari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keck USC School of Medicine, Los Angeles, California</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silke Thode, Ph.D.</last_name>
    <email>clinicalresearch@advancedbionics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Madison Gray</last_name>
    <phone>(661) 362-1794</phone>
    <email>Madison.Gray@advancedbionics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Keck USC School of Medicine</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurel M. Fisher, PhD</last_name>
      <phone>213-764-2827</phone>
      <email>Laurel.Fisher@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Elina Kari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>House Clinic</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawna Mills, AuD, CCC-A</last_name>
      <email>dmills@houseclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Georgetown University School of Medicine</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meggin van der Hilst, AuD</last_name>
      <phone>202-944-5300</phone>
      <email>Meggin.P.vanderHilst@gunet.georgetown.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Hoa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampa Bay Hearing and Balance Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Medical Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Adkins, AuD</last_name>
      <phone>859-218-2177</phone>
      <email>mmadki2@email.uky.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Orr</last_name>
      <phone>507-284-1231</phone>
      <email>orr.paula@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Colin W. Driscoll, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Missouri</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Schneider, MS</last_name>
      <phone>573-882-2549</phone>
      <email>schneiderri@health.missouri.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Holden, AuD, CCC-A</last_name>
      <phone>314-362-7245</phone>
      <email>HoldenL@ent.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Richard A. Chole, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Ear Institute/St. Luke's Health System</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Zlomke, AuD, CCC-A</last_name>
      <phone>816-932-1671</phone>
      <email>sking@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>Robert D. Cullen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Waltzman, PhD</last_name>
      <phone>212-263-7567</phone>
      <email>Susan.Waltzman@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>John T Roland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Ear Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geraldine Chissoe</last_name>
      <email>Geraldine-Chissoe@ouhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt Bill Wilkerson Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashudee Kirk</last_name>
      <phone>615-936-2491</phone>
      <email>ashudee.kirk@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>David Haynes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Ear, Nose &amp; Throat Clinic</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Morton, AuD</last_name>
      <phone>512-836-8786</phone>
      <email>smorton@austinent.com</email>
    </contact>
    <investigator>
      <last_name>James Kemper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2014</study_first_submitted>
  <study_first_submitted_qc>July 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2014</study_first_posted>
  <last_update_submitted>July 5, 2017</last_update_submitted>
  <last_update_submitted_qc>July 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cochlear Implant</keyword>
  <keyword>HiRes™ 90K Advantage implant</keyword>
  <keyword>Cochlear Implantation</keyword>
  <keyword>HiFocus™ Mid-Scala electrode</keyword>
  <keyword>Listening Benefits</keyword>
  <keyword>Adults</keyword>
  <keyword>Cochlear Implant Benefit</keyword>
  <keyword>Electrical Stimulation</keyword>
  <keyword>Electro-Acoustic Stimulation (EAS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Ear Diseases</mesh_term>
    <mesh_term>Hearing Disorders</mesh_term>
    <mesh_term>Otorhinolaryngologic Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Imidacloprid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

